Artificial Intelligence, Machine Learning, and Data Science's positive impact on the Pharma Industry and patients are astounding.

In this episode, Tommaso Mansi, Vice President, AI/ML and Digital Health, R&D, The Janssen Pharmaceutical Companies of Johnson & Johnson talks about the development of AI approaches to the development of medications and treatments for specific diseases with the help of digitized biomedical data. Tommaso shares the importance of having proper data governance in the research lab and why humans will always be necessary to produce breakthroughs in partnership with AI.

Tune in and learn more about AI's role in data in R&D!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Healthcare marketing seeks to drive stakeholders’ behaviors toward a joint goal.

In this episode of Marketing Mondays, Andreea Borcea has a chat with Vania Cao, Senior Marketing Manager at Natera, about how marketing can impact healthcare customers by learning from neuroscience and approaching them as human beings to understand segmentation. Human behavior is the marketing foundation, and our environments shape it. Identifying those external aspects is crucial in the segmentation process, and finding the right starter niche will bring the rest of the market along.

Tune in to learn about Natera’s approach to marketing and how it is making an impact in healthcare!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

When healthcare meets any other profession, amazing things happen; this is how two engineers created a completely novel anti-cancer treatment.

In this episode, CEO Lana Volokh, and CTO Alex Tendler, co-founders of ExProTher, talk about how their company is developing first-in-class cancer treatments. This oncology therapeutic delivers p53 protein into tumor cells using extracellular vesicle-based technology. They tell the story of how two engineers embarked on an entrepreneurial journey in the healthcare space and how they have overcome every barrier they have faced.

Tune in to learn more about ExProTher’s new proposal for cancer treatment!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

There is a gold rush happening in the epigenetics field, and this company is offering the most sophisticated tools to find it!

In this episode, Andrea Johnstone, Senior Director of Product Development at EpiCypher, talks about epigenetics and how they develop next-generation tech and tools to target chromatin regulatory processes, restore normal gene expression, and prevent disease. Andrea explains thoroughly what epigenetics consist of, what chromatin is, and the role that it plays in cell development.

Tune in and learn about epigenetics and how LabOps support this field!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Data can teach us about human health, it’s time to invest in it.

In this episode, Vineeta Agarwala, physician, investor, and general partner at Andreesen Horowitz, commonly known as a16z, talks about digital health adoption and investing in companies with products that can pragmatically change patient care and increase workforce efficiency. Vineeta speaks about not only being an investor but also a practicing physician and how that impacts her perspective on innovative digital health startups and trends in the healthcare space.

Tune in to this episode to learn about the direction the healthcare industry is heading in terms of digital health adoption!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Advancements in Research are Never a Straight Line

In this episode, Ulf Hannelius, President and CEO at Diamyd Medical gives us an inside scoop on their development of an innovative medicine for Type 1 Diabetes and explains how the path to success is often a function of tenacity, focus, and community. Ulf starts by talking about the business model, explicitly outsourcing and manufacturing, around an asset like Diamyd. He tells the story of Diamyd’s failure, the approaches they tried to bring positive results, and what they learned from them, like discovering the molecule’s effect with the right HLA haplotype.

Please tune in to learn about the research work at Dyamid and how they came back from the ashes!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Until recently, healthcare didn't have the right tools to address mental health.

In this episode, Dr. Tom Young, chief medical officer and founder of Proem Behavioral Health, talks about how his company provides caregivers with a process model and tools to improve equality and parity in mental health. Dr. Young shares how Proem makes every step visible to the caregiver, allowing them to follow their patient's progress. He also discusses biometrics as a game-changer in diagnostics and treatments.

Tune in to learn more about how the mental health environment is changing for the better with the help of Proem!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

As a system, healthcare can benefit from embracing a culture of collaboration and safety, something the whole world got to see during the COVID-19 pandemic.

In this episode, Michael J. Reidy, a senior consultant at Interaction Associates, talks about how his company uses tools, programs, and techniques to build a safety culture, improve leadership, and develop conscious collaboration in workplaces. He discusses behavioral aspects, like thinking and attitude, that can play a role in building a trusting environment and affect leadership.

Tune in to learn how Interaction Associates is working with teams to implement safe culture practices for the better!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Many young companies could use a little help.

In this episode, Ornella Kossi, lab operations associate at BioLabs Heidelberg, talks about her job within the company and how they facilitate the growth of many startups in the lab space. BioLabs does this by providing them with access to infrastructure, lab operations management, community, big pharma partners, and mentors who can guide them through the difficult hoops of being an early-stage company. Ornella discusses the challenges startups can face when they are beginning and how BioLabs can take the burden for them in a very focused and customized manner.

Tune in and learn more about how BioLabs helps many young companies entering the lab industry!

Click this link to the show notes, transcript, and resources: outcomesrocket.health